Related Experiment Video
Updated: Aug 14, 2026
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
[Molecular biology of oligodendroglial tumors]
F Laigle-Donadey1, A Benouaich-Amiel, K Hoang-Xuan
1Service de Neurologie Mazarin, Université P.-et M.-Curie, Groupe Hospitalier Pitié-Salpêtrière, Paris.
Abstract:
Oligodendrogliomas have been the focus of considerable interest over the last decade, ever since they were recognized as chemosensitive tumors. However, the histological diagnosis remains highly controversial and unsatisfactory. Meanwhile, our understanding of glioma oncogenesis improved greatly. Gliomas are the consequence of specific genetic or epigenetic alterations - activations of oncogenes and inactivation of tumor suppressor genes - resulting in the disruption of critical cellular pathways and leading to phenotypic changes. Such genetic information complements the existing WHO morphological classification and, more importantly, provides additional prognostic markers. Indeed, 1p/19q deletion has been correlated with chemosensitivity in oligodendrogliomas, and is becoming more and more widely used in clinical practice. There is little doubt that emerging techniques, such as CGH-array and gene profiling will be very helpful in clinical practice for refining both classification and therapeutic indications of oligodendroglial tumors.
Insights
Oligodendrogliomas are chemosensitive tumors, but diagnosis is difficult. Genetic markers like 1p/19q deletion improve classification and predict treatment response, aiding clinical practice.
Area of Science:
- Neuro-oncology
- Molecular Pathology
Background:
- Oligodendrogliomas are recognized as chemosensitive tumors, sparking significant research interest.
- Histological diagnosis of oligodendrogliomas is currently controversial and lacks satisfactory accuracy.
- Advances in understanding glioma oncogenesis reveal genetic/epigenetic alterations driving tumor development.
Purpose of the Study:
- To explore the role of genetic alterations in refining oligodendroglioma classification.
- To highlight the prognostic value of genetic markers in oligodendroglial tumors.
- To assess the clinical utility of emerging molecular techniques for diagnosis and treatment.
Main Methods:
- Review of current understanding of glioma oncogenesis.
- Analysis of genetic alterations, including 1p/19q deletion.
- Discussion of emerging techniques like CGH-array and gene profiling.
Main Results:
- Genetic information complements the WHO morphological classification of gliomas.
- 1p/19q deletion is a validated marker for chemosensitivity in oligodendrogliomas.
- Emerging techniques show promise for improved classification and therapeutic guidance.
Conclusions:
- Genetic markers provide crucial prognostic information for oligodendrogliomas.
- Molecular techniques are essential for refining the diagnosis and treatment of oligodendroglial tumors.
- Integrating genetic data will enhance clinical decision-making for these brain tumors.
